.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
QuintilesIMS
Queensland Health
Cerilliant
Johnson and Johnson
Boehringer Ingelheim
Harvard Business School
AstraZeneca
Healthtrust
Novartis

Generated: June 25, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,361,676

« Back to Dashboard

Which drugs does patent 7,361,676 protect, and when does it expire?


Patent 7,361,676 protects ULORIC and is included in one NDA. There has been one Paragraph IV challenge on Uloric.

This patent has twelve patent family members in twelve countries.

Summary for Patent: 7,361,676

Title:Solid preparation containing single crystal form
Abstract:There are provided a solid preparation containing a single crystal of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid, an excipient and a disintegrating agent, and a method for producing the same.
Inventor(s): Iwai; Michio (Osaka, JP), Nakamura; Kazuhiro (Yamaguchi, JP), Dohi; Masahiko (Tokyo, JP), Mochizuki; Hiroko (Yamaguchi, JP), Mochizuki; Seiji (Yamaguchi, JP)
Assignee: Teijin Limited (Osaka, JP)
Application Number:10/503,391
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Takeda Pharms Usa
ULORIC
febuxostat
TABLET;ORAL021856-001Feb 13, 2009RXYesNo7,361,676► SubscribeY
Takeda Pharms Usa
ULORIC
febuxostat
TABLET;ORAL021856-002Feb 13, 2009RXYesYes7,361,676► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 7,361,676

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2002-090889Mar 28, 2002
PCT Information
PCT FiledMarch 28, 2003PCT Application Number:PCT/JP03/03962
PCT Publication Date:October 09, 2003PCT Publication Number: WO03/082279

International Patent Family for Patent: 7,361,676

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office1488790► SubscribeC20140037 00152Estonia► Subscribe
Cyprus1115490► Subscribe
Denmark1488790► Subscribe
China101836978► Subscribe
Canada2474674► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
McKinsey
Merck
Johnson and Johnson
McKesson
Deloitte
Chinese Patent Office
Medtronic
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot